Table 5.
Investigation | Uses | Strengths and limitations |
---|---|---|
Microbiological studies | ||
Microscopy | Diagnosis of TB | Strengths: Specificity high; useful in all specimen types; rapid (<1 h) detection; low cost. Limitations: Sensitivity very low, especially in young children; highly operator-dependent; labor intensive; unable to distinguish viable and dead bacilli. |
Culture | Diagnosis of TB; drug susceptibility testing | Strengths: Specificity high. Limitations: Sensitivity moderate to low in young children; slow turnaround time; need proper laboratory facilities. |
DNA detection (PCR) | Strengths: Specificity high; fully automated; rapid turnaround. Limitations: Sensitivity moderate to low in young children; unable to distinguish viable from dead bacilli. | |
Histopathological studies | ||
Stained tissue samples | Diagnosis of TB | Allows exclusion of other diagnoses (such as malignancy). |
Immune-based studies | ||
TST; IGRA (e.g., Quantiferon Gold) | Diagnosis of Mtb infection | Neither test can differentiate Mtb infection from TB disease; careful evaluation of discordant results. TST: Affected by BCG vaccination; requires a second visit after 48–72 h. IGRAs: Unaffected by BCG vaccination; single visit; reduced sensitivity in very young and/or immune-compromised children; collecting adequate volume of blood and indeterminate results problematic. |
Imaging | ||
Radiography CT and MRI Ultrasonography |
Diagnosis of TB | Chest radiography (AP and lateral views) most helpful; CT or MRI useful in uncertain or complicated cases; ultrasonography useful to identify intraabdominal/retroperitoneal lymphadenopathy or pleural/pericardial effusions, highly operator-dependent. |
Data adapted from Perez-Velez and Marais 2012.
TST, tuberculin skin test; IGRA, interferon-γ release assay; CT, computed tomography; MRI, magnetic resonance imaging.